Early Detection and Management of Pseudomonas Bacteremia in a Patient With Complex Cystic Fibrosis: A Case Report

Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.Affected individuals have defective chloride channels, resulting in abnormal fluid transport across epithelial surfaces.These abnormalities can lead to systemic diseases and complications, with the most prominent being recurrent pulmonary infections.This report describes the case of a 28-year-old male patient who was diagnosed with CF at birth and had a past medical history positive for recurrent small-bowel obstructions, multiple pulmonary embolisms, bronchiectasis, and recurrent pneumonias with polymicrobial growth found on bronchoscopy.He also had chronic respiratory failure, requiring 2 L of nasal cannula oxygen therapy at home for 24 hours.Initial antibiotic therapy included IV piperacillin-tazobactam and vancomycin, then cefepime and vancomycin, which only partially treated the systemic bacteremia.After susceptibility testing, IV cefepime was discontinued, and IV meropenem and amikacin were added to the regimen.This antimicrobial therapy resulted in normalization of the white blood cell count and clearance of bacteremia prior to discharge.The patient was prescribed oral ciprofloxacin based on susceptibility testing at discharge to complete an extra 14-day course of antibiotics to eliminate the possible recurrence of systemic bacteremia.This case highlights the importance of early detection of antimicrobial susceptibility testing when initial empiric antibiotic therapy is less effective at treating bacteremia.Furthermore, it emphasizes the importance of prompt blood culture testing to quickly identify the causative organism and determine susceptibilities to effectively treat infections in patients with comorbidities who are at risk of being infected with multidrug-resistant organisms, while starting immediate treatment with a broad-coverage antibiotic regimen.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-13
DOI
https://doi.org/10.7759/cureus.119608
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Early Detection and Management of Pseudomonas Bacteremia in a Patient With Complex Cystic Fibrosis: A Case Report

Carlos H. Zambrano, Tyson Tetoff, Anoushka Mukherjee, Malak S Hamed et al.
Cureus
Cystic Fibrosis Research Advances
article

Early Detection and Management of Pseudomonas Bacteremia in a Patient With Complex Cystic Fibrosis: A Case Report

Carlos H. Zambrano, Tyson Tetoff, Anoushka Mukherjee, Malak S Hamed, Jincy A Abraham
article en

Abstract

Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.Affected individuals have defective chloride channels, resulting in abnormal fluid transport across epithelial surfaces.These abnormalities can lead to systemic diseases and complications, with the most prominent being recurrent pulmonary infections.This report describes the case of a 28-year-old male patient who was diagnosed with CF at birth and had a past medical history positive for recurrent small-bowel obstructions, multiple pulmonary embolisms, bronchiectasis, and recurrent pneumonias with polymicrobial growth found on bronchoscopy.He also had chronic respiratory failure, requiring 2 L of nasal cannula oxygen therapy at home for 24 hours.Initial antibiotic therapy included IV piperacillin-tazobactam and vancomycin, then cefepime and vancomycin, which only partially treated the systemic bacteremia.After susceptibility testing, IV cefepime was discontinued, and IV meropenem and amikacin were added to the regimen.This antimicrobial therapy resulted in normalization of the white blood cell count and clearance of bacteremia prior to discharge.The patient was prescribed oral ciprofloxacin based on susceptibility testing at discharge to complete an extra 14-day course of antibiotics to eliminate the possible recurrence of systemic bacteremia.This case highlights the importance of early detection of antimicrobial susceptibility testing when initial empiric antibiotic therapy is less effective at treating bacteremia.Furthermore, it emphasizes the importance of prompt blood culture testing to quickly identify the causative organism and determine susceptibilities to effectively treat infections in patients with comorbidities who are at risk of being infected with multidrug-resistant organisms, while starting immediate treatment with a broad-coverage antibiotic regimen.

Cureus
Saint Francis University (US)
Good health and well-being
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon